NanoViricides (NYSE-A:NNVC) shares have gained nearly 20% this week after news that it has begun evaluating its clinical-stage antiviral NV-387 for the treatment of measles, a disease with no currently approved drug treatment.
“A drug for measles is at present a completely missing link in the response to measles virus outbreak,” said Anil Diwan, executive chairman of NanoViricides said in a statement earlier this week. “Viral spread cannot be contained without an effective drug to minimize illness and stop the virus transmission from the patients.”
As the U.S. grapples with a surge in electricity demand fueled by AI, electric vehicles, and a reindustrialization push, President Donald Trump has unveiled a sweeping plan to revive the nation’s coal industry. But will this political revival clash with economic reality?
In this guest article, Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW), explores why coal’s comeback may be short-lived—and why smart money is flowing toward renewables instead.
Shares of Hertz Global (NYSE:HTZ) jumped more than 25% at Thursday’s open after Bill Ackman’s Pershing Square Capital Management disclosed a 20% stake in the car rental company worth $46 million.
The stock had already surged 50% in aftermarket trading the previous evening, marking one of Hertz’s sharpest rallies in years amid renewed investor optimism.
Reconnaissance Energy Africa Ltd (TSX-V:RECO, OTCQX:RECAF) said it has signed a memorandum of understanding with Angola’s national oil regulator for a joint exploration project in the Etosha-Okavango basin, its first move into onshore Angola.
The agreement with the Agência Nacional de Petróleo, Gás e Biocombustíveis (ANPG) gives ReconAfrica exclusive rights during the MOU period to explore a 5.2-million-acre block in southeastern Angola, complementing the Canadian firm’s existing 6.3-million-acre license in neighboring Namibia.
Iofina PLC (AIM:IOF, OTC:IOFNF) told investors it produced 124.1 tonnes of crystalline iodine in the first quarter of 2025, in line with 123.7 tonnes in the same period last year.
Output was impacted by extreme winter conditions in Oklahoma, it noted, with the cold weather disrupting the hydrocarbon operations that feed brine water availability to the plants.
Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) reported gold sales of 22,750 ounces in the first quarter of 2025, generating US$61.9 million of revenue.
It saw a realised gold price of US$2,720 per ounce – and, against a backdrop of soaring gold prices, the miner unwound all its hedges.
Livium Ltd is in advanced negotiations to secure a new contract with national metal recycler Sell & Parker Pty Ltd that is expected to generate revenue exceeding A$1 million. The Proposed Agreement would represent approximately 15% of Livium’s total revenue for the 2024 financial year, marking a significant step forward in the company’s commercial strategy.
Sell & Parker is a nationally recognised metal recycling business, employing more than 400 people across eight facilities nationwide.
Lumos Diagnostics Holdings Ltd has achieved a significant milestone in the commercial rollout of its FebriDx® rapid diagnostic test in the United States, securing reimbursement coverage with two of the seven Medicare Administrative Contractors (MACs). The approved reimbursement rate of US$41.38 per test will take effect from April 2025.
Medicare plays a critical role in the US healthcare reimbursement system, accounting for between 20% and 24% of the national payor mix. Securing MAC-level reimbursement is a key gateway to broader market access, including acceptance by private insurers who often follow Medicare’s lead. Lumos is currently in advanced negotiations with three of the remaining five MACs.